Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, and initial efficacy of SKG0106 given by intravitreal injection in patients with diabetic macular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• SKG0106

Snippet

Sponsor: Wang Min | Conditions: Diabetic Macular Edema | Phase 1 | Status: RECRUITING